Here are the top federal officials who have left their roles after clashing with DOGE
As the hard-charging DOGE has sought to make its imprint on the federal government, several high-profile officials have ...
Pharmaceutical Technology5d
How CNS researchers are handling clinical trial turbulence
The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...
Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
With RFK Jr. in charge, supplement makers see chance to cash in
Last fall, before being named the senior U.S. health official, Robert F. Kennedy Jr. said the Trump administration would ...
Mirum Pharmaceuticals announces FDA approval for Ctexli tablets
Mirum Pharmaceuticals (MIRM) announced that the FDA has approved Ctexli tablets, a bile acid, for the treatment of adults with cerebrotendinous ...
Ardelyx announces approval of NDA by China for tenapanor
Ardelyx (ARDX) announced the approval of a New Drug Application, NDA, by China’s Center for Drug Evaluation of the National Medical Products ...
Healio1d
FDA approves expanded label for Izervay
This is a developing news story. Please check back soon for updates. The FDA approved expanded prescribing information for ...
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
CNN4d
Ozempic and Wegovy are no longer in shortage, FDA says
“We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming that Novo Nordisk is meeting or exceeding current and projected ...
BioPharma Dive1d
Mirum drug for rare genetic disease gains FDA approval
Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendinous xanthomatosis, in a 2023 deal with ...